Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) issued a corrective disclosure regarding its preliminary financial results for the three-month period ended 31 March 2026.

The amendment follows an initial announcement published on 3 May 2026.

The company clarified that the earnings per share (EPS) for the first quarter (Q1) of 2026 was SAR 0.55, rather than the SAR 0.52 previously reported. This updated figure compares to an EPS of SAR 0.59 recorded during the same period of the previous year.

SPIMACO noted that the correction specifically addresses the EPS calculation for the three months ended 31 March 2026, while other financial data remains as originally disclosed.

The company’s previous filing on 3 May 2026 had incorrectly stated the profitability metric before this adjustment.